Virtmed gains $43 million in second round of fundingVirtmed has secured more than $43 million from investors in its second round of funding. Among the investors are eHealth Technology Fund, New Enterprise Associates, Frazier & Co., and the
Virtmed has secured more than $43 million from investors in its second round of funding. Among the investors are eHealth Technology Fund, New Enterprise Associates, Frazier & Co., and the venture arm of 3Com. Virtmed is a three-year-old Cambridge, MA, firm that is banking on the integration of wireless devices, Internet technologies, and existing healthcare information systems to give doctors and nurses access to patient and other data at the point of care.
Virtmeds primary product is a thin-client server designed to sit on-site and direct data between existing databases and handheld devices. The firm has also developed online reporting functions to allow users to update patient charts remotely.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.